Simulations Plus (SLP) Preliminary Revs. for FQ4 and FY2012
Tweet
Share
E-mailGet Alerts SLP Hot Sheet
Price: $18.40 +0.11%
Financial Fact:
Income from operations: 2.79M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Income from operations: 2.79M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Simulations Plus, Inc. (Nasdaq: SLP) released preliminary revenues for its fourth fiscal quarter of fiscal year 2012, ended August 31, 2012 (4QFY12), and for the entire fiscal year 2012 (FY12).
Preliminary revenues for the pharmaceutical software and services portion of the business increased to a new fourth quarter record of $1.640 million, compared to $1.427 million in 4QFY11.
Preliminary revenues for the pharmaceutical software and services portion of the business increased to a new fiscal year record of $9.449 million in FY12, compared to $8.739 million in FY11.
Preliminary revenues for the pharmaceutical software and services portion of the business increased to a new fourth quarter record of $1.640 million, compared to $1.427 million in 4QFY11.
Preliminary revenues for the pharmaceutical software and services portion of the business increased to a new fiscal year record of $9.449 million in FY12, compared to $8.739 million in FY11.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Robo.ai completes acquisitions, plans interim report for Aug. 24
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
Create E-mail Alert Related Categories
GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
